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Early and reversible changes to the
hippocampal proteome in mice on
a high-fat diet
Fiona H. McLean1,2, Fiona M. Campbell2, Domenico Sergi2, Christine Grant2, Amanda C. Morris2, Elizabeth A. Hay3,
Alasdair MacKenzie3, Claus D. Mayer4, Rosamund F. Langston1 and Lynda M. Williams2*
Abstract
Background: The rise in global obesity makes it crucial to understand how diet drives obesity-related health
conditions, such as premature cognitive decline and Alzheimer’s disease (AD). In AD hippocampal-dependent
episodic memory is one of the first types of memory to be impaired. Previous studies have shown that in mice fed
a high-fat diet (HFD) episodic memory is rapidly but reversibly impaired.
Methods: In this study we use hippocampal proteomics to investigate the effects of HFD in the hippocampus.
Mice were fed either a low-fat diet (LFD) or HFD containing either 10% or 60% (Kcal) from fat for 3 days, 1 week or
2 weeks. One group of mice were fed the HFD for 1 week and then returned to the LFD for a further week. Primary
hippocampal cultures were challenged with palmitic acid (PA), the most common long-chain saturated FA in the
Western diet, and with the anti-inflammatory, n-3 polyunsaturated FA, docosahexaenoic acid (DHA), or a
combination of the two to ascertain effects of these fatty acids on dendritic structure.
Results: HFD-induced changes occur in hippocampal proteins involved in metabolism, inflammation, cell stress, cell
signalling, and the cytoskeleton after 3 days, 1 week and 2 weeks of HFD. Replacement of the HFD after 1 week by a
low-fat diet (LFD) for a further week resulted in partial recovery of the hippocampal proteome. Microtubule-
associated protein 2 (MAP2), one of the earliest proteins changed, was used to investigate the impact of fatty acids
(FAs) on hippocampal neuronal morphology. PA challenge resulted in shorter and less arborised dendrites while DHA
had no effect when applied alone but counteracted the effects of PA when FAs were used in combination. Dendritic
morphology recovered when PA was removed from the cell culture media.
Conclusion: This study provides evidence for the rapid and reversible effects of diet on the hippocampal proteome
and the impact of PA and DHA on dendritic structure.
Keywords: Hippocampus, Proteomics, Mice, High-fat diet, Dendritic morphology
Background
The underlying causes of spontaneous Alzheimer’s dis-
ease (AD) are not fully understood [1]. While a number
of gene polymorphisms are associated with increased
risk of AD, there is mounting evidence that environmen-
tal factors, particularly obesity, type 2 diabetes and an
unhealthy diet, are major driving forces in its develop-
ment [2, 3]. The current global obesity epidemic is
mirrored by an increasing incidence of AD which is pro-
jected to quadruple by 2050 [4, 5]. This growing strength
of association between diet and AD highlights the im-
portance of understanding mechanisms linking nutrition
and cognition.
Abnormal protein regulation in the hippocampus is a
major pathological hallmark of AD, mainly in the form
of β-amyloid plaques (Aβ) and neurofibrillary hyperpho-
sphorylated tau tangles (NFT) [1, 6]. However, loss of
dendritic arborisation [7] and synaptic failure are both
reported to occur prior to the formation of Aβ and NFT
[8] suggesting that earlier, as yet unidentified, events
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underlie the onset of this disease. Thus, it is important
to identify these pathophysiological processes and deter-
mine what drives them.
Animal studies show that a high-fat diet (HFD) leads
to obesity and causes cognitive impairment [9–11].
These studies and others have mostly looked at the
relatively long-term impact of a HFD on memory
from around 5 days onwards. However, we have re-
cently shown rapid cognitive decline in hippocampal-
dependent episodic memory, in mice, within 1 day of
a HFD, which persisted for the time that animals
remained on the diet [12]. Nonetheless, when mice
were switched back to a low-fat diet (LFD) episodic
memory was restored. In order to understand the
potential mechanisms underlying the rapid and
reversible onset of this cognitive impairment, changes
in the hippocampal proteome were examined in a co-
hort of mice from the same experiment. Primary hip-
pocampal cell culture was then used to confirm the
influence of different dietary fatty acids (FAs) on
dendritic morphology.
Methods
Animal study
Male, 12 week old, C57Bl/6 J mice (Harlan Laboratories,
UK) were used for proteomic studies and Sprague-Dawley
rat pups (n = 8) were used for primary hippocampal cul-
tures. All studies adhered to UK Home Office regulations
according to the Animals (Scientific Procedures) Act,
1986, were in accordance with the European Directive
on the Protection of Animals used for Scientific
Purposes 2010/63/E, and followed ARRIVE guidelines.
Experimental protocols were approved by the Rowett
Institute’s Ethical Review Committee. Animals were
singly housed on grid floors and maintained on a 12:
12 h light:dark cycle with access to food and water ad
libitum. Environmental enrichment was provided.
Low-fat diet (10% energy from fat) D12450B and
high-fat diet (60% energy from fat) D12492 (Research
Diets Inc. New Jersey, US) were used. Mice were fed
a LFD for 8 days to acclimatise to a semi-purified diet
and then either remained on the LFD for a further 2
weeks or were switched to a HFD for 3 days, 1 week
or 2 weeks or were fed a HFD for 1 week then
switched back to a LFD for a week (high-fat diet
recovery (HFDR)). Mice were counterbalanced be-
tween groups based on body weight at the beginning
of the experiment (n = 6 mice per diet group per time
point). Mice were euthanised by an intraperitoneal in-
jection of 200 mg/ml pentobarbital sodium (Dunlops,
UK) per kg body weight followed by decapitation and
dissection. Brains were then snap-frozen on dry ice as
previously described [12].
Body weight and food intake measurements
Body weight and food intake were measured 3 times
weekly and on the day of diet switch.
Sample preparation
Whole mouse brains were stored at − 80 °C until dissec-
tion. Hippocampi were removed and tissue was weighed
and homogenised in 40mM Tris pH 7.4, 0.1% v/v Triton
X-100 containing Roche complete protease inhibitors
(Sigma Aldrich, UK) at a 1:4 tissue to buffer ratio. Pro-
tein concentrations of samples were calculated using a
Pierce 660 nm Protein Assay (Thermo Fisher Scientific,
UK). Samples were diluted with 15 μl DTT in a variable
volume of buffer in order to load 200 μg of protein.
Protein from a single mouse hippocampus was used for
each gel.
Two-dimensional gel electrophoresis (2-DE)
For separation of proteins in the first dimension, 17 cm
immobilized pH gradient (IPG) strips (pH 3–10)
(BioRad, US) were used. Strips containing 200 μg of pro-
tein sample were hydrated for 1 h at 20 °C in hydration
buffer (7M urea; 2M thiourea; 4% w/v CHAPS; 2% w/v
Biolyte; and 50 mM DTT) in an IEF cell (Bio-Rad, US)
without applied voltage. Samples were isoelectrically fo-
cussed at 50 V/strip for 16 h and then incubated for 10–
15min at room temperature in equilibrium buffer (6M
urea; 2% w/v SDS; 0.375M Tris-HCl, pH 8.8; 20% v/v
glycerol; and 130 mM DTT) followed by incubation for
10–15min at room temperature in a second equilibra-
tion buffer (6M urea; 2% w/v SDS; 0.375M Tris-HCl,
pH 8.8; 20% v/v glycerol; and 135 mM iodoacetamide).
Strips were loaded on to an 18x18cm gel cassette with
5 μl of All Blue Precision Protein Standards (Bio-Rad,
US) as a reference and run at 200 V for 9.5 h or until the
bromophenol blue had reached the bottom of the gel.
Coomassie Blue (Brilliant Blue G, Sigma-Aldrich, UK)
was then used to fix and stain the gels. After staining
gels were transferred to a clean tray containing deionised
H2O and any residual Coomassie Blue was removed.
Gels were then shaken for 2 h in fresh deionised H2O
which was replaced every hour. Gels were scanned and
sealed in a plastic bag with approximately 5 ml of deio-
nised H2O to prevent dehydration until spots were
excised.
Image analysis
Images of the 2-DE gels were analysed using PDQuest 2-
D Analysis Software (Bio-Rad, US). Average optical
densities of spots were measured and compared using
Student’s t-test at each time point. Each group had 6
gels per group corresponding to one gel per animal
except the HFD and corresponding LFD control group
at 2 weeks which had 5 gels per group as one gel from
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each group was removed due to low protein loading.
Spots which showed significant differences between
groups (p < 0.05) were manually cut from gels using a
modified pipette tip.
Mass spectrometry
Isolated spots were trypsinized using the MassPrep
Station (Waters, Micromass, UK) protocol. Tryptic pep-
tides were then analysed by LC-MS/MS as previously
described [13, 14] using ‘Ultimate’ nanoLC system (LC
Packings, UK) and a Q-Trap (Applied Biosystems/MDS
Sciex, UK) triple quadrupole mass spectrometer fitted
with a nanospray ion source.
Protein identification, functional classification and
pathway analysis
Protein identifications were made by entering the total
ion current (TIC) data into the MASCOT search engine
(Matrix Science, UK) using the MSDB database.
Functional classification and protein information was re-
trieved from the Uniprot database http://www.uniprot.
org). Where proteins fall under more than 1 functional
classification the protein is included in both. Uniprot
accession numbers were then entered into Reactome
(http://www.reactome.org) to establish the pathways and
reactions associated with the proteins.
Primary hippocampal cell cultures
Primary hippocampal cell cultures were derived from
postnatal day 2 (P2) Sprague-Dawley rat pups (n = 8).
The hippocampi were dissected, pooled and incubated
in 2 ml trypsin for 15 min at 37 °C. Trypsin was replaced
with 2ml soybean trypsin inhibitor (Sigma-Aldrich, UK)
for 5 min at room temperature. Soybean trypsin inhibi-
tor was then replaced with 3 ml of supplemented media
(Neurobasal-A medium with 2% B27 supplement, 1%
Glutamax and 1% Penicillin/Streptomycin, all Gibco,
UK). Tissue was triturated gently using a fire polished
glass pipette to dissociate the tissue then media was re-
moved and passed through a cell sieve into collection
tube. Twoml of media was added to the remaining tis-
sue then the process repeated approximately another 10
times. Cells were then plated onto poly-L-lysine coated
coverslips in 24 well plates at a density of 180,000 cells
per well. Cells were cultured on coverslips in medium
(Neurobasal-A medium with 2% B27 supplement, 1%
Glutamax and 1% Penicillin/Streptomycin, all Gibco,
UK) at 37 °C and 5% CO2 for 7 days.
Fatty acid conjugation
Both palmitic acid (PA) and docosahexaenoic acid (DHA)
were conjugated to standard FA-free bovine serum
albumin (BSA) (Sigma, Catalogue Number A6003) as
described previously [15] with some alterations [16]. Fatty
acids (FA) were dissolved in 0.1M NaOH at either 37 °C
or 70 °C for DHA or PA respectively in a shaking
water bath to give a final concentration of 20 mM.
FA-free BSA was dissolved at 55 °C in deionised
water. The 20 mM FA solution was mixed with BSA
to obtain a 1:4 BSA:FA molar ratio (2 mM FA: 0.5
mM BSA) as previously reported [17] and then vor-
texed for 10 s. The mixture was then incubated in a
shaking water bath at 37 °C or 55 °C for DHA or PA,
respectively. Mixtures were brought back to room
temperature, filter sterilised using a 0.22 μM pore size
membrane then stored at − 20 °C. FA conjugates were
then diluted in culture medium to give the appropriate
working concentrations.
Fatty acid challenge
After 7 days in culture, primary hippocampal cell cul-
tures were challenged with either 200 μM PA, 200 μM
DHA, 200 μM PA plus 125 μM DHA or BSA as a
control for 6 h. Cultures were also challenged with either
BSA or PA for 3 h. To ascertain whether or not recovery
from PA occurs, cells challenged with PA for 3 h were
washed before incubation with BSA for a further 3 h. To
ensure there was no effect of the washing procedure on
experimental outcomes, cells incubated for 3 h with BSA
or PA were washed and treatments were reintroduced
for a further 3 h.
Immunocytochemistry
After FA challenge, the plates were placed on ice, media
was removed and the cells were fixed with ice-cold 4%
paraformaldehyde for 20 min, washed in PBS (3 X 5
min) then permeabilised with 0.2% Triton X-100 for 15
min. Cells were washed 3 times with PBS. Non-specific
staining was blocked with 8% BSA dissolved in PBS for
20 min. Cells were incubated in primary antibody rabbit
anti-MAP2 (Abcam, UK) at [1:1000] for 1 h followed by
3 washes in PBS. Cells were then incubated in secondary
antibody goat anti-rabbit Alexa Fluor 488 (Molecular
Probes, USA) at [1:1000] for 1 h. Both primary and
secondary antibodies were diluted in PBS containing 4%
BSA and 0.2% Triton X-100. Control slides omitted the
primary antibody which resulted in a complete lack of
staining (data not shown). Coverslips were mounted
onto glass slides using Vectashield (Vector Laboratories,
UK). Cells were imaged using a Leica DMR microscope
fitted with a QImaging QICAM FAST 1394 digital
camera.
MAP2 quantifications
Staining was analysed in images capture by fluorescence
microscopy using WIS-NeuroMath software [18, 19].
This software allows for accurate measurements of cell
morphology. Ten neurons per treatment were analysed.
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Statistics
One-way ANOVAs were carried out (using the Statistical
Package for the Social Sciences (SPSS), USA) to compare
neuronal area, number of dendrite branches from the cell
body, average length of projections and number of
branching points. When there were more than two
groups, a Least Significant Difference (LSD) post-hoc
comparison was carried out. Significance was p ≤ 0.05.
Results
Body weight and food intake
Mice on a HFD showed increased body weight and were
significantly heavier (p < 0.05) than the LFD mice at day
3 and 1 week of diet and had a significantly higher
calorie intake at day 3 (p < 0.05). When HFD mice were
switched to a LFD (high-fat diet recovery - HFDR), caloric
intake was the same as those on a LFD (Fig. 1a-h).
Hippocampal proteome on a high-fat diet (HFD) and HFD
recovery (HFDR)
The HFD changed the pattern of hippocampal protein
expression with 58 spots (46 unique proteins identified),
36 spots (28 unique proteins identified) and 27 spots (22
unique proteins identified) being altered compared to
mice on a LFD after 3 days, 1 and 2 weeks respectively.
When mice were switched after 1 week of HFD back to
a LFD for 1 week (high-fat diet recovery - HFDR), 14
spots (11 unique proteins identified) were significantly
altered compared to those on a LFD (Fig. 2a-d;
Additional file 1: Tables S1–S4, Additional file 4: Tables
S1-S4 References).
Pathway analysis
On a HFD, proteins related to metabolism, the cytoskel-
eton, cellular stress, the immune system and cell signal-
ling were changed. On returning to a LFD after a HFD
(HFDR) no proteins associated with the immune system
or cell signalling remained changed (Figs. 3 and 4).
Reactome analysis identified the biochemical path-
ways with the most changed proteins. These included
metabolism, signal transduction, axon guidance, deve-
lopmental biology, carbohydrate metabolism, haemos-
tasis, cell cycle, signalling by G Protein-Coupled
Receptors (GPCR), the immune system and platelet
activation, signalling and aggregation (Additional file 1:
Tables S5–S8).
Neuronal area and number of proximal dendrites in
primary hippocampal cell cultures
When primary hippocampal cell cultures were chal-
lenged with PA, DHA or a combination of the two FAs
there were no differences in the area covered by MAP2
immunopositive neurons nor in the number of proximal
dendrites from individual neurons compared to the con-
trol BSA group after 3 h (Additional file 2: Figure S1)
and 6 h (Fig. 5a and c). There were also no differences in
neuronal area in cells treated with PA followed by
incubation with BSA (Fig. 5a and c).
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Average length of dendrites in primary hippocampal cell
cultures
The average length of dendrites was significantly shorter
after both a 3 h (Additional file 1: Figure S1) and a 6
h challenge with PA compared to the BSA control
(Fig. 5b). There was no difference in dendrite length
in either DHA alone or in PA plus DHA challenged
neurons relative to BSA-treated neurons. Additionally,
dendritic length in neurons treated with PA followed
by BSA was not different to BSA control (Fig. 5b).
When investigating if cells could recover from a PA
challenge, to ensure that any shearing forces resulting
from changing solutions was ruled out as an influence
on dendrite length, PA containing media and BSA
containing control media were replaced after 3 h. The
same differences between PA and BSA control were
maintained under these conditions.
Number of dendrite branching points in primary
hippocampal cell cultures
Hippocampal neurons challenged with PA had fewer
branching points compared with BSA controls after
both 3 h (Additional file 1: Figure S1) and 6 h
challenge (Fig. 5d). There was no difference in the
number of branching points between either DHA
alone or PA plus DHA compared to BSA control.
The number of branching points in neurons that were
treated with PA followed by incubation with BSA was
not different to BSA control (Fig. 5d). As described
above changing solutions was ruled out as an
influence on number of branching points as the same
differences between PA and BSA control were main-
tained under these condition.
Dendritic morphology in primary hippocampal cell cultures
Representative fluorescent images of MAP2 immuno-
staining showed dendritic morphology in hippocampal
neurons challenged with both DHA alone and PA plus
DHA had comparable morphology to BSA control
neurons whilst neurons treated with PA showed reduced
dendritic arborisation (Fig. 6a-e). Neurons treated with
PA also showed dendritic blebbing consisting of local-
ised swellings that gave a beads on a string appearance.
Neurons challenged with PA plus DHA and DHA alone
were comparable to BSA control with no dendritic bleb-
bing (Fig. 6Ai-Ei). Neuronal challenges in which the PA
Fig. 2 Images of two-dimensional gel electrophoresis (2-DE) of hippocampal proteins after a HFD with changed spots circled at 3 days, 1 week, 2
weeks and 2 weeks recovery. Numbers on gels refer to spots found in Additional file 1: Tables S1-S4
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Fig. 3 Heat map showing fold changes in proteins after 3 days, 1 week, 2 weeks of HFD and HFDR. Proteins are shown in multiples reflecting the
number of spots which gave the same protein ID. High-fat diet (HFD) and high-fat diet recovery (HFDR)
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was replaced by BSA still exhibited blebbing but to a
lesser degree than when PA was present in the media
(Fig. 6E and Ei).
Discussion
Proteomic analysis demonstrates rapid changes in
specific proteins and pathways in the hippocampus in
response to a HFD, however, in the present study it is
not possible to say whether these are due to changes in
protein expression and/or turnover or post-translational
modifications. Nonetheless proteins found to change the
most in the present study cluster into diverse pathways
involved in metabolism, cellular stress responses, cyto-
skeletal organisation, cell signalling and the immune
3 Days HFD
1 Week HFD
2 Weeks HFD
2 Weeks HFDR
Fig. 4 Pie charts showing the percentage of proteins changed from
each functional group after 3 days, 1 week, 2 weeks HFD and HFDR.
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Fig. 5 a. Area of microtubule-associated protein 2 (MAP2)
immunostaining in primary hippocampal neurons in culture b.
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from soma d. Number of dendritic branching points. Neurons were
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serum albumin (BSA), palmitic acid (PA) and docosahexaenoic
acid (DHA)
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system with almost half of the altered proteins also linked
to aging, memory processes and neurodegeneration.
The fact that many of the proteins changed by a HFD
are involved in metabolism is unsurprising due to the
switch from carbohydrate to fats as the primary energy
substrate. Thus, metabolic changes in the brain induced
by a HFD underlie alterations in hippocampal metabolic
enzymes implying an adaptation and perhaps impair-
ment of cellular metabolism with lipid oversupply pro-
moting neuronal inflammation and lipotoxicity [20].
Disruption of brain nutrient and energy metabolism has
been established as a cause of cognitive impairment and
central in the development of AD [21]. Hippocampal
neurons are particularly susceptible to metabolic dysreg-
ulation as they often have long neurites which require
more energy. This large surface area makes these neu-
rons more prone to cytoskeletal impairment as well as
increasing their risk of exposure to surrounding environ-
mental conditions [22]. Therefore, neurons are suscep-
tible to an increase in long-chain saturated fatty acid
supply which may compromise efficient energy meta-
bolism given the detrimental effect this can have on
mitochondria, the power house of the cells [23].
One of the metabolic enzymes changed in response to
a HFD is the glycolytic enzyme triose-phosphate isome-
rise, which has been linked to both Aβ and tau protein
aggregation, with higher levels in AD patients [24, 25].
Others include, lactoylglutathione lyase and mitochon-
drial hydroxyacylglutathione hydrolase, two enzymes
changed by a HFD which are involved in the detoxifica-
tion of methylglyoxal which may be exacerbated in our
model given the presence of both long-chain saturated
fatty acids and refined carbohydrates in our experimen-
tal diet. Methylglyoxal is one of the most reactive glyca-
tion agents produced in vivo [26] glycating proteins,
nucleotides and lipids and leading to the formation of
advanced glycation end products (AGEs), which are
causative in tissue damage seen in diabetes [27] and
associated with AD [28]. Hippocampal neurons are par-
ticularly susceptible to methylglyoxal-induced neurotox-
icity characterised by inflammation and apoptotic cell
death [29, 30].
Another group of metabolic enzymes that show
changes across all three time points on a HFD are the
glutathione S-transferases. These proteins catalyse gluta-
thione conjugation to a range of electrophilic com-
pounds and have a role in cellular detoxification [31] by
suppressing cellular levels of lipid peroxidation which
can induce apoptosis [32]. Reduced activities of gluta-
thione S-transferases in the hippocampus and related
brain regions, as well as depleted protein levels in cere-
brospinal fluid (CSF), have been found in AD patients
[33]. The enzyme creatine kinase B-type maintains local
ATP/ADP ratio by catalysing the transfer of high energy
A B
C D
Ai Bi
Ci Di
E
Ei
Fig. 6 Representative images of microtubule-associated protein 2
(MAP2) immunostaining captured with fluorescence microscopy
showing dendritic morphology in hippocampal neurons challenged
for 6 h with: A. BSA alone (control) B. 200 μM PA C. 200 μM DHA D.
200 μM PA plus 125 μM DHA E. 200 μM PA for 3 h followed by BSA
for 3 h. Scale bar: 20 μm. Ai-Ei. Higher magnification fluorescence
microscopy of MAP2 immunostaining showing dendritic
morphology in hippocampal neurons challenged for 6 h with: Ai.
BSA alone (control) Bi. 200 μM PA Ci. 200 μM DHA Di. 200 μM PA
plus 125 μM DHA. Ei. 200 μM PA for 3 h followed by BSA for 3 h.
Bovine serum albumin (BSA), palmitic acid (PA) and
docosahexaenoic acid (DHA). Scale bar: 10 μm. Bovine serum
albumin (BSA), palmitic acid (PA) and docosahexaenoic acid (DHA)
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phosphate groups from ATP to phosphocreatine thus
playing a pivotal role in brain cellular energy homeosta-
sis. Not surprisingly, given the impact of a HFD on
energy metabolism, this enzyme, was also changed by a
HFD and is reported to be dysregulated and oxidised in
AD [34, 35].
Many proteins identified as changed by a HFD are
linked to cell stress and cell death, including a number
of heat shock proteins (HSPs) which are changed by a
HFD at all time points tested. These proteins respond to
oxidative, mitochondrial and endoplasmic reticulum
stress, all of which are known to be induced by a HFD
[36]. HSPs act as molecular chaperons and have roles in
correcting protein misfolding, improper protein aggre-
gation, mediation of protein targeting to organelles and
have a protective role in cellular regulation [37].
Changes in HSPs are indicative of cellular stress and can
be interpreted as an attempt to reinstate protein homeo-
stasis to prevent protein dysfunction.
Other enzymes involved in limiting neuronal damage
include peroxiredoxin-1 (PRDX1) and peroxiredoxin-2
(PRDX2), both changed by a HFD. PRDXs are antioxi-
dant, peroxide-scavenging proteins and as such have
neuroprotective functions in inflammation and oxidative
stress [38, 39]. Changes in both HSPs and peroxiredo-
xins in response to a HFD confirm HFD-induced protein
misfolding, oxidative stress and neuronal cell death, key
features of neurodegenerative diseases [38, 40].
Unexpectedly, a HFD also caused changes in hippo-
campal proteins involved in the cytoskeleton, particu-
larly proteins which have roles in tubulin and
microtubule (MT) stability including microtubule-as-
sociated protein 2 (MAP2) and stathmin. MT stability
plays a crucial role in the organisation of neurites,
cell communication and memory [41]. Proteins which
regulate actin are also changed by a HFD including
fascin and actin-related protein 3, which are import-
ant for the organisation of actin filaments. Actin fila-
ments and actin polymerization are key in dendritic
spine formation which are crucial for memory forma-
tion [42].
Both dihydropyrimidinase-related protein 1 (DRP-
1) and dihydropyrimidinase-related protein 2 (DRP-2)
were changed by a HFD. DRP-1 is key in dendritic
spine morphology [43] with DRP-1 knock-out mice
exhibiting reduced long-term potentiation in the
hippocampus, deficits in hippocampal-dependent
spatial memory tasks and decreased and disorganised
MAP2 staining in the dendrites of hippocampal cells
[44]. DRP-2 is also crucial for neutrite organisation
[45, 46] and mouse studies have implicated hyper-
phosphorylated DRP2, driven by the overexpression
of amyloid precursor protein (APP), as an early indicator
of AD [47].
There were also HFD-induced changes in amyloid beta
A4 precursor protein-binding family B member 3
(FE65L2), which binds to and processes APP [46, 48].
APP has been implicated in the regulation of neuronal
actin-based membrane motility processes [49]. Taken to-
gether, these numerous changes in cytoskeletal organi-
sation almost certainly influence neurite functionality
changing neuronal communication required for learning
and memory.
Neuroinflammation has previously been associated
with a HFD and cognitive impairment [11, 50], this is
supported by the present study which shows changes in
proteins associated with inflammation. These proteins
included S100-B, phosphatidylethanolamine-binding
protein 1, E3 ubiquitin-protein ligase Trim36, disabled
homolog 2-interacting (DAB2IP) and mitogen-activated
protein kinase 1 (MAPK1). These findings add to the
evidence implicating inflammation as a cause of cogni-
tive dysfunction as demonstrated by the manifestation of
long-term memory deficits in mice overexpressing
inflammatory cytokines in the hippocampus [51] and
provide further support to the putative role of neuro-
inflammation as a mediator of HFD-induced cognitive
impairment.
Hippocampal proteins in mice recovering from a HFD
(HFDR) revealed a proteome that had almost returned
to control levels. However, it should be noted that the
bodyweight and intake of mice at this time had already
recovered to control levels, indicating that some alter-
ations in the proteome involved in this recovery may
have been missed. Of the 11 identified proteins which
changed in HFDR, 5 have also been reported to change
as a result of exercise including fructose-bisphosphate
aldolase A (ALDOA), fructose bisphosphate aldolase C
(ALDOC), peroxiredoxin-2, DRP-2 and neurofilament
light polypeptide (NFL) [52]. Changes to the hippocam-
pal proteome induced by switching from a HFD to a
LFD and increasing exercise show some overlap, thus,
demonstrating that exercise induced changes in
hippocampal metabolism appear in part to resemble the
metabolic switch from HFD to LFD.
To further investigate the impact of a HFD on the
cytoskeleton, hippocampal primary cell cultures were
challenged with different FAs and immunostained for
MAP2. PA challenge reduced the length of dendrites,
the number of dendritic branches and induced dendritic
‘blebbing’ consisting of localised swellings along the
length of a dendrite which give the appearance of beads
on a string. Blebbing is thought to be the result of the
accumulation of proteins and membranous organelles
due to cytoskeletal degradation usually seen in studies
on excitoxicity and ischemia and is recognised as an
early hallmark of neural toxicity [53, 54]. PA effects are
rapidly reversed when PA is removed from the media.
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This supports our proteomic data where replacing a
HFD with a LFD results in the return of the proteome
to almost control levels.
Unlike PA, challenge with DHA did not change den-
dritic morphology and when administered at the same
time as PA, DHA protected against the effects of PA.
Several mechanisms may underlie this effect. Cell studies
have shown that DHA is anti-inflammatory by decreas-
ing the release of pro-inflammatory cytokines such as
TNF-α, IL-6 and IL-8 and increasing release of the anti-
inflammatory cytokine IL-10 [55]. Also, DHA exhibits
antioxidant effects in rodent models of aging and AD
[56]. Furthermore, n-3 polyunsaturated fatty acids have
been shown to modulate fatty acid metabolism by
increasing their catabolism via a mechanism which in-
volves increased fatty acid β-oxidation within mitochon-
dria [57]. Increased fatty acid catabolism may, in turn,
counteract the detrimental effect exerted by PA on hip-
pocampal neurons by preventing PA-induced neuronal
toxicity and the build-up of lipotoxic lipid species such
as ceramide [58]. Thus, the present study not only
supports the fact that DHA is beneficial to neuronal
function but demonstrates that it can counter the effects
of PA.
Conclusions
In conclusion, this study shows rapid and reversible
changes in the hippocampal proteome in response to a
HFD with approximately 40% of the proteins changed by
a HFD also associated with AD [33, 35, 57–66]. These
similarities provide further support for changes in energy
metabolism as underlying the development of cognitive
disorders with a HFD playing a key role in accelerating
this process. A large number of the proteins changed by
a HFD have cytoskeletal functions and primary hippo-
campal cell cultures challenged with PA show inhibition
of dendritic arborisation and dendritic blebbing indi-
cating changes in the cytoskeleton whereas DHA and
the absence of PA can reverse these changes. Previous
studies have implicated HFD in changes in the cytoske-
leton [13, 67] and our study further bolsters this evi-
dence by providing a mechanism through which a HFD
can impact synaptogenesis, cognition and memory (Add-
itional file 3: Figure S2). Further investigation is needed
however, to elucidate processes involved in the inter-
action of a HFD with the cytoskeleton.
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